As shown in Figure 1B, the results indicated lower PPARG expression levels in nine types of cancer, including LUSC, ovarian serous cystadenocarcinoma (OV), BRCA, CESC, HNSC, SKCM, THCA, UCEC, and uterine carcinosarcoma (UCS). Here, PPARG is linked to cancer.